Visitors at Chr. Hansen’s booth at the SupplySide West 2010 trade show taking place Oct. 20 through 23 in Las Vegas, NV, USA, will be able to see, taste and hear about Chr. Hansen’s newest probiotic products.
“We will be bringing our newest probiotic offerings to this year’s SupplySide West, such as new strains and a new product concept,” says Charlotte Beyerholm, Marketing Manager, Human Health & Nutrition, Chr. Hansen. “Furthermore, visitors at our stand will have a chance to taste our new samples of probiotic sticks and chewable probiotic tablets in various flavors.”
"Right now we are marketing Lactobacillus fermentum PCC® and Lactobacillus F19®, the two most recent extensions to our Probio-Tec® range of probiotic strains with documented effect, and we will of course be promoting these strains in Las Vegas, too.” PCC® is a very promising strain within immune health and F19® has documented effect within gastrointestinal health.
“Earlier this year we launched our combined probiotics and fiber concept for improved digestive health which paves the way for powerful anti-constipation supplements containing efficacious probiotics and beneficial fibers,” says Beyerholm. The supplement format is a 6 g stick with powder to be sifted over breakfast cereals or poured into a glass of water daily or twice a day.
“With the interest in probiotics at an all-time high, we expect to welcome more people than ever to the Chr. Hansen booth at this year’s SupplySide West show,” says Brian Peeters, Strategic Sales Manager, Chr. Hansen Inc. “Today’s consumers are looking for a probiotic product that delivers on its promises and Chr Hansen’s clinically documented range of Probio-Tec® strains consistently deliver targeted health benefits.”
Chr. Hansen at SupplySide West 2010
Booth no. 26047 in the exhibitor hall
Visit our SupplySide West 2010 website: www.chr-hansen.com/ssw
Chr. Hansen is a global bioscience company that develops natural ingredient solutions for the food, nutritional, pharmaceutical and agricultural industries. The products include cultures, enzymes, probiotics and natural colors, and all solutions are based on strong research and development competencies coupled with significant technology investments. Revenue in the 2013/14 financial year was EUR 756 million. The company holds a leading market position in all its divisions: Cultures & Enzymes, Health & Nutrition and Natural Colors. It has more than 2,500 dedicated employees in over 30 countries and main production facilities in Denmark, France, USA and Germany. Chr. Hansen was founded in 1874 and is listed on NASDAQ OMX Copenhagen.